Standout Papers

Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study 2024 202642
  1. Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study (2024)
    Björn Pasternak, Viktor Wintzell et al. BMJ

Immediate Impact

1 from Science/Nature 61 standout
Sub-graph 1 of 22

Citing Papers

Metabolic dysfunction-associated steatotic liver disease in adults
2025 Standout
Mapping the effectiveness and risks of GLP-1 receptor agonists
2025 Standout
2 intermediate papers

Works of Viktor Wintzell being referenced

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
2020
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study
2019
and 2 more

Author Peers

Author Last Decade Papers Cites
Viktor Wintzell 298 190 87 125 24 581
Joel Freiman 150 158 168 96 20 591
Carlo Acierno 171 94 176 87 27 550
Sun-Hye Ko 251 128 100 62 37 587
Qun Yan 67 208 60 81 33 521
Marschelle H. Power 86 156 54 58 31 654
Lucienne C.J.M. Lemaire 53 202 190 85 24 674
S. D. Mohamed 145 241 66 79 16 694
Emrullah Solmazgül 75 361 79 69 25 715
Min Zhuo 256 121 51 164 37 724
Gisella Pitter 323 405 127 52 18 626

All Works

Loading papers...

Rankless by CCL
2026